Wan Cheng Chow

5.4k total citations · 2 hit papers
48 papers, 3.9k citations indexed

About

Wan Cheng Chow is a scholar working on Epidemiology, Hepatology and Infectious Diseases. According to data from OpenAlex, Wan Cheng Chow has authored 48 papers receiving a total of 3.9k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Epidemiology, 35 papers in Hepatology and 4 papers in Infectious Diseases. Recurrent topics in Wan Cheng Chow's work include Liver Disease Diagnosis and Treatment (30 papers), Hepatitis B Virus Studies (26 papers) and Hepatitis C virus research (20 papers). Wan Cheng Chow is often cited by papers focused on Liver Disease Diagnosis and Treatment (30 papers), Hepatitis B Virus Studies (26 papers) and Hepatitis C virus research (20 papers). Wan Cheng Chow collaborates with scholars based in Singapore, China and Hong Kong. Wan Cheng Chow's co-authors include DF Gray, Yun‐Fan Liaw, Cha‐Ze Lee, Oliver N. Keene, Hon K. Yuen, Jonathan S. Dixon, Tawesak Tanwandee, Geoffrey C. Farrell, Joseph J.�Y. Sung and Satawat Thongsawat and has published in prestigious journals such as New England Journal of Medicine, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Wan Cheng Chow

45 papers receiving 3.8k citations

Hit Papers

Lamivudine for Patients with Chronic Hepatitis B and Adva... 2004 2026 2011 2018 2004 2005 500 1000 1.5k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Lamivudine for Patients with Chronic Hepatitis B and Advanced Liver Disease
    2004 1.7k citations Yun‐Fan Liaw, Joseph J.�Y. Sung et al. New England Journal of Medicine profile →
  2. Peginterferon Alfa-2a, Lamivudine, and the Combination for HBeAg-Positive Chronic Hepatitis B
    2005 1.1k citations Wan Cheng Chow et al. New England Journal of Medicine profile →

Peers

Wan Cheng Chow
Tai‐Chung Tseng Taiwan
Chih‐Lin Lin Taiwan
Yun‐Fan Liaw Taiwan
Chin–Lan Jen Taiwan
Liang‐Yen Wang Taiwan
Tawesak Tanwandee Thailand
Hélène Fontaine France
Tatsuya Ide Japan
Danny Ka‐Ho Wong Hong Kong
Ming‐Yang Lai Taiwan
Tai‐Chung Tseng Taiwan
Wan Cheng Chow
Citations per year, relative to Wan Cheng Chow Wan Cheng Chow (= 1×) peers Tai‐Chung Tseng

Countries citing papers authored by Wan Cheng Chow

Since Specialization
Citations

This map shows the geographic impact of Wan Cheng Chow's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wan Cheng Chow with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wan Cheng Chow more than expected).

Fields of papers citing papers by Wan Cheng Chow

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wan Cheng Chow. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wan Cheng Chow. The network helps show where Wan Cheng Chow may publish in the future.

Co-authorship network of co-authors of Wan Cheng Chow

This figure shows the co-authorship network connecting the top 25 collaborators of Wan Cheng Chow. A scholar is included among the top collaborators of Wan Cheng Chow based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wan Cheng Chow. Wan Cheng Chow is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bert, Nina Le, Apostolos Koffas, Rajneesh Kumar, et al.. (2025). Rapid whole-blood immune profiling reveals heterogeneous HBV-specific T cell response patterns independent of clinical disease phases. Journal of Hepatology. 83(6). 1292–1304. 2 indexed citations
2.
Chen, Vivian Chih-Wei, Wharton O. Y. Chan, Wan Rong Sia, et al.. (2024). Inflammasome-Driven Fatal Acute-on-Chronic Liver Failure Triggered by Mild COVID-19. Viruses. 16(10). 1646–1646. 2 indexed citations
3.
Tan, Anthony T., Nicole Tan, Thinesh Lee Krishnamoorthy, et al.. (2024). A rapid method to assess the in vivo multi-functionality of adoptively transferred engineered TCR T cells. PubMed. 4(1). ltae007–ltae007.
4.
5.
Lin, Kenneth W., Rajneesh Kumar, Feng Shen, et al.. (2023). The utility of non‐invasive tests to assess advanced fibrosis in Asian subjects with chronic hepatitis B and concomitant hepatic steatosis. Liver International. 43(5). 1008–1014. 5 indexed citations
6.
Chan, Wah‐Kheong, George Boon‐Bee Goh, Vincent Wai‐Sun Wong, et al.. (2023). Hepatic steatosis and metabolic risk factors among patients with chronic hepatitis B: The multicentre, prospective CAP‐Asia study. Journal of Viral Hepatitis. 30(4). 319–326. 3 indexed citations
7.
Zhang, Xinrong, George Boon‐Bee Goh, Wah‐Kheong Chan, et al.. (2020). Unhealthy lifestyle habits and physical inactivity among Asian patients with non‐alcoholic fatty liver disease. Liver International. 40(11). 2719–2731. 46 indexed citations
8.
Chang, Pik‐Eu, et al.. (2020). Validation of the Expanded Baveno-VI Criteria for Screening Gastroscopy in Asian Patients with Compensated Advanced Chronic Liver Disease. Digestive Diseases and Sciences. 66(4). 1343–1348. 3 indexed citations
9.
Wong, Vincent Wai‐Sun, Pietro Lampertico, Victor de Lédinghen, et al.. (2015). Probability-Based Interpretation of Liver Stiffness Measurement in Untreated Chronic Hepatitis B Patients. Digestive Diseases and Sciences. 60(5). 1448–1456. 15 indexed citations
10.
Goh, George Boon‐Bee, et al.. (2015). Perceptions of non-alcoholic fatty liver disease – an Asian community-based study. Gastroenterology report. 4(2). 131–135. 37 indexed citations
11.
Wang, Who-Whong, Rajneesh Kumar, Andi Utama, et al.. (2013). Identification of Serum Monocyte Chemoattractant Protein-1 and Prolactin as Potential Tumor Markers in Hepatocellular Carcinoma. PLoS ONE. 8(7). e68904–e68904. 33 indexed citations
12.
Tan, Anthony T., Long Hoàng, Daniel J. Chin, et al.. (2013). Reduction of HBV replication prolongs the early immunological response to IFNα therapy. Journal of Hepatology. 60(1). 54–61. 62 indexed citations
13.
Sablan, Benjamin, Dong Joon Kim, Nina G. Barzaga, et al.. (2012). Demonstration of safety and enhanced seroprotection against hepatitis B with investigational HBsAg-1018 ISS vaccine compared to a licensed hepatitis B vaccine. Vaccine. 30(16). 2689–2696. 54 indexed citations
14.
15.
Thong, Bernard Yu‐Hor, Ee Tzun Koh, Hiok Hee Chng, & Wan Cheng Chow. (2007). Outcomes of Chronic Hepatitis B Infection in Oriental Patients with Rheumatic Diseases. Annals of the Academy of Medicine Singapore. 36(2). 100–105. 18 indexed citations
16.
Liaw, Yun‐Fan, Joseph J.�Y. Sung, Wan Cheng Chow, et al.. (2004). Lamivudine for Patients with Chronic Hepatitis B and Advanced Liver Disease. New England Journal of Medicine. 351(15). 1521–1531. 1712 indexed citations breakdown →
17.
Chow, Wan Cheng, et al.. (2002). Prevalence of hepatitis G virus infection in patients with liver diseases in Singapore.. PubMed. 43(2). 67–9. 2 indexed citations
18.
Chow, Wan Cheng, et al.. (2002). Wild‐type and ‘a’ epitope variants in chronic hepatitis B virus carriers positive for hepatitis B surface antigen and antibody. Journal of Gastroenterology and Hepatology. 17(2). 148–152. 18 indexed citations
19.
20.
Chow, Wan Cheng, et al.. (1997). Acute Viral Hepatitis E. Journal of Clinical Gastroenterology. 24(4). 235–238. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tai‐Chung Tseng Breakdown of academic impact, for papers by Chih‐Lin Lin Breakdown of academic impact, for papers by Yun‐Fan Liaw Breakdown of academic impact, for papers by Chin–Lan Jen Breakdown of academic impact, for papers by Liang‐Yen Wang Breakdown of academic impact, for papers by Tawesak Tanwandee Breakdown of academic impact, for papers by Hélène Fontaine Breakdown of academic impact, for papers by Tatsuya Ide Breakdown of academic impact, for papers by Danny Ka‐Ho Wong Breakdown of academic impact, for papers by Ming‐Yang Lai
Rankless by CCL
2026